🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

12 results for “Cartesian Therapeutics” Clear

  1. Decartes-08

    Cartesian Therapeutics

    Myasthaenia Gravis

    phase 3 mab active

    1 trial

  2. Placebo to Descartes-08, Descartes-08

    Cartesian Therapeutics

    generalized myasthenia gravis

    phase 3 small molecule active

    1 trial

  3. Descartes 08

    Cartesian Therapeutics

    Myeloma Multiple

    phase 2 mab terminated

    1 trial

  4. Descartes-08

    Cartesian Therapeutics

    Childhood-onset Systemic Lupus Erythematous

    phase 2 small molecule active

    1 trial

  5. Descartes-08

    Cartesian Therapeutics

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial

  6. Descartes-08

    Cartesian Therapeutics

    Antisynthetase Syndrome

    phase 2 small molecule active

    1 trial

  7. Descartes-08

    Cartesian Therapeutics

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule active

    1 trial

  8. Descartes-11

    Cartesian Therapeutics

    Multiple Myeloma

    phase 2 mab terminated

    2 trials

  9. Descartes 30

    Cartesian Therapeutics

    Acute Respiratory Distress Syndrome

    phase 1 mab terminated

    1 trial

  10. Descartes-08

    Cartesian Therapeutics

    Multiple Myeloma

    phase 1 mab terminated

    1 trial

  11. Descartes-15

    Cartesian Therapeutics

    Refractory Multiple Myeloma

    phase 1 small molecule terminated

    1 trial

  12. Descartes-25

    Cartesian Therapeutics

    Multiple Myeloma

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources